6069-0822 Screening compound: 2-(furan-2-yl)-5-methyl-N,7-diphenyl-4H,7H-[1,2,4]triazolo[1,5-a]pyrimidine-6-carboxamide

6069-0822 Screening compound: 2-(furan-2-yl)-5-methyl-N,7-diphenyl-4H,7H-[1,2,4]triazolo[1,5-a]pyrimidine-6-carboxamide
6069-0822 Screening compound: 2-(furan-2-yl)-5-methyl-N,7-diphenyl-4H,7H-[1,2,4]triazolo[1,5-a]pyrimidine-6-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound 6069-0822
2-(furan-2-yl)-5-methyl-N,7-diphenyl-4H,7H-[1,2,4]triazolo[1,5-a]pyrimidine-6-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

6069-0822

Molecular Formula

C23H19N5O2 (C23 H19 N5 O2)

Compound Name

2-(furan-2-yl)-5-methyl-N,7-diphenyl-4H,7H-[1,2,4]triazolo[1,5-a]pyrimidine-6-carboxamide

IUPAC name

2-(furan-2-yl)-5-methyl-N7-diphenyl-4H7H-[124]triazolo[15-a]pyrimidine-6-carboxamide

SMILES

CC(Nc1nc(-c2ccco2)nn1C1c2ccccc2)=C1C(Nc1ccccc1)=O

InChI

InChI=1S/C23H19N5O2/c1-15-19(22(29)25-17-11-6-3-7-12-17)20(16-9-4-2-5-10-16)28-23(24-15)26-21(27-28)18-13-8-14-30-18/h2-14,20H,1H3,(H,25,29)(H,24,26,27)/t20-/m0/s1

InChI Key

TWYMPYISGROVEB-FQEVSTJZSA-N

MDL Number (MFCD)

MFCD05716500

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

397.44

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.960

Distribution Coefficient, logD

3.960

Water Solubility, LogSw

-4.04

Polar Surface Area

68.447

Acid Dissociation Constant (pKa)

11.24

Base Dissociation Constant (pKb)

3.06

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

8.70

6069-0822 in Drug Discovery

Included in Screening Libraries

3D-Biodiversity Library (27607 compounds)

C-Met Library (15277 compounds)

Human Proteases Annotated Library (2868 compounds)

Selective Target Activity Profiling Library (14702 compounds)

Aurora A-B Kinases Targeted Library (9426 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Target Identification, Phenotypic Screening library (TIPS) (27612 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Endocrine
  • Cancer
  • Digestive system
  • Male
  • Female
  • Hemic and lymphatic
Targets:
  • Kinases
  • Kinases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with 6069-0822 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 6069-0822?
Check Price and Availability of 6069-0822, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 6069-0822 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 6069-0822
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 6069-0822
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 6069-0822 available by request